← Leaderboards
Ellis L Reinherz
Dana-Farber Cancer Institute
$59,058,313
Attributed
$59,058,313
Total exposure
36
Grants
30
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $8.1M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$128,008,096 · 42
By mechanism
P01$55,853,049 · 16
U19$36,148,452 · 9
R01$22,258,187 · 8
U01$6,378,806 · 1
R37$4,438,136 · 1
P30$1,306,670 · 1
Top collaborators
- Matthew J. Lang6 shared
Others in their field
Top investigators on “Structure”
- David Heimbrook · Leidos Biomedical Research, Inc.$475,333,582
- Barton F Haynes · Duke University$444,977,767
- Lawrence Corey · Fred Hutchinson Cancer Center$334,646,086
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$315,257,203
Research focus
StructureAntigensDesignT-LymphocyteBaseEpitopesAntibodiesNeutralizing AntibodyLinkMediatingInfectionCellsProteinsSurfacePeptidesViralSiteSpecificityLigandsVaccinationVaccine DevelopmentMolecular ConformationLipidsVariant
Grant awards (158)
Biology and structure of pMHC receptors functioning as mechanosensors in the [alpha][beta] T-cell lineage$2,705,373
P01 · FY2025 · AI · contact PI
RNA-based HIV-1 chimera vaccines encoding a trimerizing host self-protein protomer linked to a viral MPER-TM segment$2,256,224
P01 · FY2025 · AI · contact PI
Structural characterization of MPER-TM immunogens$881,996
P01 · FY2025 · AI · contact PI
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies$674,251
R01 · FY2025 · CA · contact PI
Administrative Core$450,896
P01 · FY2025 · AI · contact PI
Pre-TCR Mechanotransduction: From Biology to Structure$450,895
P01 · FY2025 · AI · contact PI
Administrative Support Core$99,384
P01 · FY2025 · AI · contact PI
Biology and structure of pMHC receptors functioning as mechanosensors in the [alpha][beta] T-cell lineage$2,414,693
P01 · FY2024 · AI · contact PI
RNA-based HIV-1 chimera vaccines encoding a trimerizing host self-protein protomer linked to a viral MPER-TM segment$2,356,969
P01 · FY2024 · AI · contact PI
Structural characterization of MPER-TM immunogens$940,588
P01 · FY2024 · AI · contact PI
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies$640,540
R01 · FY2024 · CA · contact PI
Administrative Core$163,356
P01 · FY2024 · AI · contact PI
Ligand-dependent preTCR function$131,094
P01 · FY2024 · AI · contact PI
Administrative Support Core$102,537
P01 · FY2024 · AI · contact PI
Biology and structure of pMHC receptors functioning as mechanosensors in the [alpha][beta] T-cell lineage$2,418,542
P01 · FY2023 · AI · contact PI
Ligand-dependent preTCR function$772,381
P01 · FY2023 · AI · contact PI
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies$660,767
R01 · FY2023 · CA · contact PI
Administrative Core$162,502
P01 · FY2023 · AI · contact PI
Biology and structure of pMHC receptors functioning as mechanosensors in the [alpha][beta] T-cell lineage$2,422,263
P01 · FY2022 · AI · contact PI
Ligand-dependent preTCR function$779,122
P01 · FY2022 · AI · contact PI
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies$713,250
R01 · FY2022 · CA · contact PI
NMR-based dynamic assessment of TCR transmembrane conformational states linked to T cell function$441,250
R01 · FY2022 · AI · contact PI
Administrative Core$164,684
P01 · FY2022 · AI · contact PI
Biology and structure of pMHC receptors functioning as mechanosensors in the [alpha][beta] T-cell lineage$2,425,265
P01 · FY2021 · AI · contact PI
Ligand-dependent preTCR function$781,075
P01 · FY2021 · AI · contact PI
NMR-based dynamic assessment of TCR transmembrane conformational states linked to T cell function$441,250
R01 · FY2021 · AI · contact PI
Administrative Core$162,422
P01 · FY2021 · AI · contact PI
Biology and structure of pMHC receptors functioning as mechanosensors in the [alpha][beta] T-cell lineage$2,444,290
P01 · FY2020 · AI · contact PI
Targeting Immunogenicity to the MPER Hinge and C-helix for BNAb Elicitation$1,744,691
P01 · FY2020 · AI · contact PI
Structural Approaches to HIV-1 Immunogen Design and BNAb Analysis$1,289,808
P01 · FY2020 · AI · contact PI
Ligand-dependent preTCR function$798,373
P01 · FY2020 · AI · contact PI
NMR-based dynamic assessment of TCR transmembrane conformational states linked to T cell function$441,250
R01 · FY2020 · AI · contact PI
Administrative Core$170,984
P01 · FY2020 · AI · contact PI
Administrative Core$160,435
P01 · FY2020 · AI · contact PI
Targeting Immunogenicity to the MPER Hinge and C-helix for BNAb Elicitation$1,744,691
P01 · FY2019 · AI · contact PI
Structural Approaches to HIV-1 Immunogen Design and BNAb Analysis$1,289,810
P01 · FY2019 · AI · contact PI
NMR-based dynamic assessment of TCR transmembrane conformational states linked to T cell function$441,250
R01 · FY2019 · AI · contact PI
Administrative Core$160,433
P01 · FY2019 · AI · contact PI
Targeting Immunogenicity to the MPER Hinge and C-helix for BNAb Elicitation$2,189,065
P01 · FY2018 · AI · contact PI
Structural Approaches to HIV-1 Immunogen Design and BNAb Analysis$1,734,180
P01 · FY2018 · AI · contact PI
NMR-based dynamic assessment of TCR transmembrane conformational states linked to T cell function$441,250
R01 · FY2018 · AI · contact PI
Thymocyte integrin regulation by plexinD1$424,773
R01 · FY2018 · AI · contact PI
Administrative Core$160,435
P01 · FY2018 · AI · contact PI
Targeting Immunogenicity to the MPER Hinge and C-helix for BNAb Elicitation$1,743,161
P01 · FY2017 · AI · contact PI
Structural Approaches to HIV-1 Immunogen Design and BNAb Analysis$1,301,070
P01 · FY2017 · AI · contact PI
Elucidating protective CTL immunity through physical detection of epitopes in conjunction with assessment of TCR-pMHC bond lifetimes under load$450,000
R56 · FY2017 · AI · contact PI
Thymocyte integrin regulation by plexinD1$424,773
R01 · FY2017 · AI · contact PI
Administrative Core$147,809
P01 · FY2017 · AI · contact PI
Targeting Immunogenicity to the MPER Hinge and C-helix for BNAb Elicitation$1,760,661
P01 · FY2016 · AI · contact PI
Structural Approaches to HIV-1 Immunogen Design and BNAb Analysis$1,233,525
P01 · FY2016 · AI · contact PI
Thymocyte integrin regulation by plexinD1$424,773
R01 · FY2016 · AI · contact PI
Administrative Core$127,814
P01 · FY2016 · AI · contact PI
Eliciting B cells to produce anti-HIV gp41 MPER-specific neutralizing antibodies$1,589,966
U19 · FY2015 · AI · contact PI
Structural Approches to HIV-1 Immunogen Design for BNAb Generation$1,199,463
U19 · FY2015 · AI · contact PI
Thymocyte integrin regulation by plexinD1$424,773
R01 · FY2015 · AI · contact PI
Crossprotective CTL Against Influenza$338,457
U01 · FY2015 · AI · contact PI
Administrative Core$121,412
U19 · FY2015 · AI · contact PI
Eliciting B cells to produce anti-HIV gp41 MPER-specific neutralizing antibodies$1,589,966
U19 · FY2014 · AI · contact PI
Crossprotective CTL Against Influenza$1,136,663
U01 · FY2014 · AI · contact PI
Structural Approches to HIV-1 Immunogen Design for BNAb Generation$563,736
U19 · FY2014 · AI · contact PI
Administrative Core$89,157
U19 · FY2014 · AI · contact PI
Eliciting B cells to produce anti-HIV gp41 MPER-specific neutralizing antibodies$1,495,269
U19 · FY2013 · AI · contact PI
Crossprotective CTL Against Influenza$1,108,246
U01 · FY2013 · AI · contact PI
Structural Approaches To HIV-1 Immunogen Design For BNAb Generation$540,633
R01 · FY2013 · AI · contact PI
Structural Approches to HIV-1 Immunogen Design for BNAb Generation$527,408
U19 · FY2013 · AI · contact PI
Administrative Core$79,858
U19 · FY2013 · AI · contact PI
Eliciting B cells to produce anti-HIV gp41 MPER-specific neutralizing antibodies$1,983,517
U19 · FY2012 · AI · contact PI
Crossprotective CTL Against Influenza$1,136,663
U01 · FY2012 · AI · contact PI
Structural Approches to HIV-1 Immunogen Design for BNAb Generation$1,060,577
U19 · FY2012 · AI · contact PI
Structural Approaches To HIV-1 Immunogen Design For BNAb Generation$575,141
R01 · FY2012 · AI · contact PI
T Cell Antigen Recognition$429,561
R56 · FY2012 · AI · contact PI
Administrative Core$126,338
U19 · FY2012 · AI · contact PI
Eliciting B cells to produce anti-HIV gp41 MPER-specific neutralizing antibodies$1,624,603
U19 · FY2011 · AI · contact PI
Crossprotective CTL Against Influenza$1,158,777
U01 · FY2011 · AI · contact PI
Structural Approaches To HIV-1 Immunogen Design For BNAb Generation$586,878
R01 · FY2011 · AI · contact PI
Structural Approches to HIV-1 Immunogen Design for BNAb Generation$532,178
U19 · FY2011 · AI · contact PI
Administrative Core$124,349
U19 · FY2011 · AI · contact PI
Eliciting B cells to produce anti-HIV gp41 MPER-specific neutralizing antibodies$1,640,840
U19 · FY2010 · AI · contact PI
Crossprotective CTL Against Influenza$1,500,000
U01 · FY2010 · AI · contact PI
Structural Approaches To HIV-1 Immunogen Design For BNAb Generation$592,373
R01 · FY2010 · AI · contact PI
Structural Approches to HIV-1 Immunogen Design for BNAb Generation$537,347
U19 · FY2010 · AI · contact PI
T Cell Antigen Recognition$436,153
R01 · FY2010 · AI · contact PI
Administrative Core$125,471
U19 · FY2010 · AI · contact PI
HIVRAD: Structural approaches to vaccine development$617,662
P01 · FY2009 · AI · contact PI
Protective orthopox immunization in normals and patients with cancer or eczema$598,870
U19 · FY2009 · AI · contact PI
Structural Approaches To HIV-1 Immunogen Design For BNAb Generation$592,238
R01 · FY2009 · AI · contact PI
T Cell Antigen Recognition$450,856
R01 · FY2009 · AI · contact PI
T Cell Antigen Recognition$431,502
R01 · FY2009 · AI · contact PI
Orthopox immunization in patients with cancer or eczema$3,444,555
U19 · FY2008 · AI · contact PI
HIVRAD: Structural approaches to vaccine development$1,369,131
P01 · FY2008 · AI · contact PI
Research Resource Technical Development Component$727,845
U19 · FY2008 · AI · contact PI
Structure-based design for neutralizing antibodies against SIV/HIV$666,506
P01 · FY2008 · AI · contact PI
T CELL ANTIGEN RECOGNITION$512,503
R37 · FY2008 · AI · contact PI
Biomarkers of immunity to Orthopox Viruses$434,100
U19 · FY2008 · AI · contact PI
Neutralization Core$281,226
P01 · FY2008 · AI · contact PI
Flow Cytometry Core$214,070
U19 · FY2008 · AI · contact PI
Educational Component$142,797
U19 · FY2008 · AI · contact PI
Administrative Core$135,672
P01 · FY2008 · AI · contact PI
Administrative Core$128,011
U19 · FY2008 · AI · contact PI
Protective orthopox immunization in normals and patients with cancer or eczema$3,444,553
U19 · FY2007 · AI · contact PI
HIVRAD: Structural approaches to vaccine development$707,838
P01 · FY2007 · AI · contact PI
T CELL ANTIGEN RECOGNITION$507,215
R37 · FY2007 · AI · contact PI
Structure-based design for neutralizing antibodies against SIV/HIV$133,269
P01 · FY2007 · AI · contact PI
Protein Production$101,977
P01 · FY2007 · AI · contact PI
Administrative$37,347
P01 · FY2007 · AI · contact PI
Orthopox immunization in patients with cancer or eczema$3,445,581
U19 · FY2006 · AI · contact PI
HIVRAD: Structural approaches to vaccine development$1,414,773
P01 · FY2006 · AI · contact PI
Genes encoding T cell receptors$567,894
R01 · FY2006 · AI · contact PI
T CELL ANTIGEN RECOGNITION$507,151
R37 · FY2006 · AI · contact PI
Positive selection of thymocytes$408,463
R56 · FY2006 · AI · contact PI
Orthopox immunization in patients with cancer or eczema$3,422,012
U19 · FY2005 · AI
HIVRAD: Structural approaches to vaccine development$1,409,455
P01 · FY2005 · AI
Genes encoding T cell receptors$566,522
R01 · FY2005 · AI
T CELL ANTIGEN RECOGNITION$501,805
R37 · FY2005 · AI
Orthopox immunization in patients with cancer or eczema$3,360,940
U19 · FY2004 · AI
HIVRAD: Structural approaches to vaccine development$1,371,237
P01 · FY2004 · AI
Genes encoding T cell receptors$551,920
R01 · FY2004 · AI
T CELL ANTIGEN RECOGNITION$487,189
R37 · FY2004 · AI
POSITIVE SELECTION OF THYMOCYTES$410,558
R01 · FY2004 · AI
Thymic vaccination: Manipulating the T cell repertoire$1,834,795
R01 · FY2003 · AI
Orthopox immunization in patients with cancer or eczema$1,773,663
U19 · FY2003 · AI
HIVRAD: Structural approaches to vaccine development$1,333,743
P01 · FY2003 · AI
T CELL ANTIGEN RECOGNITION$695,297
R37 · FY2003 · AI
Genes encoding T cell receptors$537,486
R01 · FY2003 · AI
POSITIVE SELECTION OF THYMOCYTES$398,600
R01 · FY2003 · AI
Thymic vaccination: Manipulating the T cell repertoire$1,859,942
R01 · FY2002 · AI
HIVRAD: Structural approaches to vaccine development$1,202,907
P01 · FY2002 · AI
Genes encoding T cell receptors$522,454
R01 · FY2002 · AI
POSITIVE SELECTION OF THYMOCYTES$386,991
R01 · FY2002 · AI
T CELL ANTIGEN RECOGNITION$378,022
R37 · FY2002 · AI
CORE--FLOW CYTOMETRY$250,404
P30 · FY2002 · CA
CORE--FLOW CYTOMETRY$250,404
P30 · FY2002 · CA
MOUSE T CELL RECEPTORS SPECIFIC FOR VESICULAR STOMATITIS VIRUS &HIV CD4 STRUCT$0
P41 · FY2002 · RR
CORE--PROTEIN PRODUCTION$0
P01 · FY2002 · AI
Structure-Based Design for Nabs against SIV/HIV$0
P01 · FY2002 · AI
MOUSE T CELL RECEPTORS SPECIFIC FOR VESICULAR STOMATITIS VIRUS &HIV CD4 STRUCT$0
P41 · FY2002 · RR
Thymic vaccination: Manipulating the T cell repertoire$2,041,678
R01 · FY2001 · AI
NOVEL HIV THERAPIES--IPCP$752,364
P01 · FY2001 · AI
GENES ENCODING T CELL RECEPTORS$526,247
R01 · FY2001 · AI
POSITIVE SELECTION OF THYMOCYTES$375,719
R01 · FY2001 · AI
T CELL ANTIGEN RECOGNITION$368,904
R37 · FY2001 · AI
CORE--FLOW CYTOMETRY$250,404
P30 · FY2001 · CA
SIV &HIV TRIMERIC ENVELOPE PROTEIN$53,566
P41 · FY2001 · RR
STRUCTURAL ANALYSIS OF CD4-LIGAND INTERACTIONS$0
P01 · FY2001 · AI
MOUSE T CELL RECEPTORS SPECIFIC FOR VESICULAR STOMATITIS VIRUS &HIV CD4 STRUCT$0
P41 · FY2001 · RR
CORE--PROTEIN PRODUCTION AND ASSAY$0
P01 · FY2001 · AI
NOVEL HIV THERAPIES--IPCP$730,450
P01 · FY2000 · AI
GENES ENCODING T CELL RECEPTORS$512,682
R01 · FY2000 · AI
T CELL ANTIGEN RECOGNITION$480,050
R37 · FY2000 · AI
POSITIVE SELECTION OF THYMOCYTES$364,775
R01 · FY2000 · AI
CORE--FLOW CYTOMETRY$305,054
P30 · FY2000 · CA
CORE--FLOW CYTOMETRY$250,404
P30 · FY2000 · CA
STRUCTURAL ANALYSIS OF CD4-LIGAND INTERACTIONS$171,998
P01 · FY2000 · AI
CORE--PROTEIN PRODUCTION AND ASSAY$171,998
P01 · FY2000 · AI
MODEL 377 DNA SEQUENCER AND ACCESSORIES$155,163
S10 · FY2000 · RR
MOUSE T CELL RECEPTORS SPECIFIC FOR VESICULAR STOMATITIS VIRUS &HIV CD4 STRUCT$58,258
P41 · FY2000 · RR
MOUSE T CELL RECEPTORS SPECIFIC FOR VESICULAR STOMATITIS VIRUS &HIV CD4 STRUCT$58,258
P41 · FY2000 · RR
SIV &HIV TRIMERIC ENVELOPE PROTEIN$11,527
P41 · FY2000 · RR